Sei Investments CO Insmed Inc Transaction History

Sei Investments CO

  • $74.7 Billion
  • Q3 2024

A detailed history of Sei Investments CO transactions in Insmed Inc stock. As of the latest transaction made, Sei Investments CO holds 333,597 shares of INSM stock, worth $24.6 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares
333,597
Previous 277,712 20.12%
Holding current value
$24.6 Million
Previous $18.6 Million 30.88%
% of portfolio
0.03%
Previous 0.03%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024
BUY
$62.0 - $79.01 $3.46 Million - $4.42 Million
55,885 Added 20.12%
333,597 $24.4 Million
Q2 2024

Aug 13, 2024
BUY
$22.0 - $69.71 $4.33 Million - $13.7 Million
196,639 Added 242.55%
277,712 $18.6 Million
Q1 2024

May 07, 2024
SELL
$25.72 - $29.94 $442,461 - $515,057
-17,203 Reduced 17.5%
81,073 $2.2 Million
Q4 2023

Feb 14, 2024
BUY
$23.42 - $31.74 $551,049 - $746,810
23,529 Added 31.48%
98,276 $3.05 Million
Q3 2023

Nov 14, 2023
BUY
$19.86 - $26.93 $817,199 - $1.11 Million
41,148 Added 122.47%
74,747 $1.89 Million
Q2 2023

Aug 11, 2023
SELL
$16.44 - $21.1 $16,029 - $20,572
-975 Reduced 2.82%
33,599 $708,000
Q1 2023

May 12, 2023
BUY
$16.26 - $21.73 $5,869 - $7,844
361 Added 1.06%
34,574 $589,000
Q4 2022

Feb 10, 2023
SELL
$16.98 - $23.15 $189,276 - $258,053
-11,147 Reduced 24.57%
34,213 $683,000
Q3 2022

Nov 14, 2022
BUY
$20.88 - $28.21 $136,805 - $184,831
6,552 Added 16.88%
45,360 $977,000
Q2 2022

Aug 15, 2022
SELL
$17.07 - $25.71 $239,457 - $360,659
-14,028 Reduced 26.55%
38,808 $761,000
Q1 2022

May 13, 2022
BUY
$20.42 - $28.13 $122,254 - $168,414
5,987 Added 12.78%
52,836 $1.24 Million
Q4 2021

Feb 14, 2022
SELL
$25.89 - $33.45 $23,637 - $30,539
-913 Reduced 1.91%
46,849 $1.27 Million
Q3 2021

Nov 12, 2021
BUY
$22.46 - $29.47 $634,203 - $832,144
28,237 Added 144.62%
47,762 $1.31 Million
Q2 2021

Aug 06, 2021
SELL
$24.17 - $36.01 $1.59 Million - $2.36 Million
-65,599 Reduced 77.06%
19,525 $551,000
Q1 2021

May 12, 2021
BUY
$32.28 - $44.3 $758,224 - $1.04 Million
23,489 Added 38.11%
85,124 $2.89 Million
Q4 2020

Feb 08, 2021
BUY
$31.45 - $40.54 $1.24 Million - $1.6 Million
39,582 Added 179.49%
61,635 $2.05 Million
Q3 2020

Nov 06, 2020
SELL
$26.0 - $34.5 $498,186 - $661,054
-19,161 Reduced 46.49%
22,053 $707,000
Q2 2020

Aug 17, 2020
BUY
$14.11 - $29.42 $144,585 - $301,466
10,247 Added 33.09%
41,214 $1.13 Million
Q2 2020

Aug 11, 2020
BUY
$14.11 - $29.42 $20,092 - $41,894
1,424 Added 4.82%
30,967 $738,000
Q1 2020

May 14, 2020
SELL
$13.63 - $33.98 $19,858 - $49,508
-1,457 Reduced 4.7%
29,543 $472,000
Q4 2019

Feb 06, 2020
BUY
$16.12 - $24.98 $11,864 - $18,385
736 Added 2.43%
31,000 $737,000
Q3 2019

Nov 12, 2019
SELL
$15.49 - $25.78 $181,310 - $301,754
-11,705 Reduced 27.89%
30,264 $531,000
Q2 2019

Aug 14, 2019
BUY
$23.0 - $32.19 $101,499 - $142,054
4,413 Added 11.75%
41,969 $1.07 Million
Q1 2019

May 15, 2019
SELL
$13.91 - $31.15 $36,625 - $82,017
-2,633 Reduced 6.55%
37,556 $1.09 Million
Q4 2018

Feb 13, 2019
BUY
$11.6 - $18.7 $153,410 - $247,307
13,225 Added 49.05%
40,189 $717,000
Q3 2018

Nov 08, 2018
BUY
$18.95 - $28.08 $241,953 - $358,525
12,768 Added 89.94%
26,964 $545,000
Q2 2018

Aug 03, 2018
SELL
$20.0 - $29.72 $14,460 - $21,487
-723 Reduced 4.85%
14,196 $335,000
Q1 2018

May 11, 2018
SELL
$21.69 - $32.99 $126,452 - $192,331
-5,830 Reduced 28.1%
14,919 $336,000
Q4 2017

Feb 08, 2018
BUY
$26.43 - $31.78 $473,493 - $569,338
17,915 Added 632.15%
20,749 $647,000
Q3 2017

Nov 06, 2017
BUY
$11.61 - $31.21 $32,902 - $88,449
2,834
2,834 $89,000

Others Institutions Holding INSM

# of Institutions
467
Shares Held
182M
Call Options Held
2.27M
Put Options Held
3.33M
View Full List

About INSMED Inc

INSM Quotes by TradingView
  • Ticker INSM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 135,476,992
  • Market Cap $10B
  • Description
  • Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversibl...
More about INSM
Track This Portfolio

Track Sei Investments CO Portfolio

Follow Sei Investments CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sei Investments CO, based on Form 13F filings with the SEC.

News

Stay updated on Sei Investments CO with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email